SEQUEL
Live / Applied — Second extension granted (statement of use) (as of 27 Feb 2026)
What this means for you
Not registered yet, but its 27 Feb 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97812964
- Mark type
- Stylized text
- Filed
- 27 Feb 2023
- Published for opposition
- 27 Feb 2024
- Attorney of record
- MARK E. TETREAULT
Goods and services
- Class 005 — Pharmaceuticals: Infusion cartridges sold pre-filled with medication for medical use in the field of cardiovascular disease, diabetes, asthma, kidney disease, and cancer; Adhesive overlays in the nature of adhesive medical tape and adhesive bandages for use with infusion pumps and associated devices, all of the foregoing for use in connection with a device for the delivery of therapeutic agents for the treatment of disease
- Class 009 — Scientific and electric apparatus: Software as a Medical Device (SaMD), downloadable, for predicting blood analyte levels and adjusting infusion pump settings based on personalized data for use in connection with a device for the delivery of therapeutic agents for the treatment of disease; Downloadable educational mobile applications featuring information and instruction on managing, treating and living with chronic disease; batteries; battery chargers
- Class 010 — Medical apparatus: Medical devices, namely, infusion and injection devices for administering therapeutic agents for the treatment of disease, and pouches and mounts used therewith; medical devices, namely, infusion pumps for delivering measured amounts of solutions into the bloodstream over time for the treatment of disease; medical apparatus for monitoring blood analyte levels for use in connection with a device for the delivery of therapeutic agents for the treatment of disease; implantable subcutaneous devices for the delivery of therapeutic agents for the treatment of disease, sold empty in the nature of medical fluid injectors; on-body medical fluid injectors for the delivery of therapeutic agents for the treatment of disease; chronic disease management devices in the nature of medical sensors for use in connection with a device for the delivery of therapeutic agents for the treatment of disease that are implanted or inserted into the human body used to continuously gather human biometric data for monitoring the concentration of analytes in the human body and also including accessories therefor, namely, receivers, sensor housings and sensor insertion devices sold as a unit; medical infusion sets comprised of infusion tubing, infusion needles, needle guards, connectors, attachment clips, and accessories therefor, all used for the delivery of therapeutic agents for the treatment of disease
- Class 035 — Advertising and business services: Providing a trade-in program for drug delivery and chronic disease management devices; Pharmaceutical services, namely, mail order pharmacy services and processing online and telephone prescription orders in retail and central fill pharmacies featuring chronic disease management supplies, medications, drugs and other prescriptions
- Class 041 — Education and entertainment services: Educational services, namely, creating and developing web-based and in person classes, seminars, workshops and programs in the field of managing and living with chronic disease; personalized training and coaching in the use of monitoring devices and infusion pumps in the treatment of chronic disease; training of healthcare providers in chronic disease treatment and the use of infusion pumps and infusion sets
- Class 042 — Scientific and technological services: Software-as-a-service (SAAS) featuring software for use in the acquisition, capture, processing, presentation, transmission and storage of medical and physiological data obtained from medical sensors that are implanted or inserted into the human body; Providing an interactive web site featuring technology that enables users to enter, access, track, monitor and generate health and medical information and reports relating to managing chronic disease, medication and analyte levels; Upgrading of computer software, namely, Software as a Medical Device (SaMD) for predicting blood analyte levels and adjusting infusion pump settings based on personalized data for use in connection with a device for the delivery of therapeutic agents for the treatment of disease
- Class 044 — Medical, beauty and agricultural services: Interactive medical monitoring and alert services for reminding infusion pump users of medicinal dosage for medical treatment purposes in the nature of monitoring and managing chronic disease; Providing medical information to infusion pump users for use in connection with a device for the delivery of therapeutic agents for the treatment of disease in the form of reports in the field of chronic disease management; Providing a website featuring general medical information related to chronic diseases, including advice on treatment options and chronic disease management; providing online searchable medical databases in the field of chronic disease management for patients, their families and caregivers, and healthcare practitioners; medical consultation services, namely, patient ambassador program to communicate medical information to people with chronic disease, all of the foregoing related to use of a device for the delivery of therapeutic agents for the treatment of disease
Owner
- DEKA Research & Development Corp., Manchester, NH, US
- DEKA Research & Development Corp., Manchester, NH, US
Prosecution history
- 28 Feb 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 27 Feb 2026 — SOU EXTENSION 2 GRANTED
- 27 Feb 2026 — SOU EXTENSION 2 FILED
- 27 Feb 2026 — SOU TEAS EXTENSION RECEIVED
- 09 Aug 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 08 Aug 2025 — SOU EXTENSION 1 GRANTED
- 08 Aug 2025 — SOU EXTENSION 1 FILED
- 08 Aug 2025 — SOU TEAS EXTENSION RECEIVED
- 18 Mar 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 03 Feb 2025 — TTAB RELEASE CASE TO TRADEMARKS
- 03 Feb 2025 — OPPOSITION TERMINATED NO. 999999
- 03 Feb 2025 — OPPOSITION DISMISSED NO. 999999
- 26 Aug 2024 — EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
- 26 Aug 2024 — OPPOSITION INSTITUTED NO. 999999
- 23 Mar 2024 — EXTENSION OF TIME TO OPPOSE RECEIVED